India yet to adopt WHO blueprint for epidemic-prone diseases
New Delhi: India is yet to adopt the blueprint developed by World Health Organisation (WHO) which allows rapid activation of research to understand epidemic-prone diseases and development of life-saving drugs to prevent those, the government said.
"WHO has developed a blueprint for a global strategy that allows rapid activation of research and development activities for better understanding of an epidemic-prone disease, development of life-saving drugs, vaccines and diagnostics for prevention of such epidemics.
"The blueprint was unveiled at the World Health Assembly held in May, 2016. As of now, India has not adopted the blueprint," Minister of State for Health Faggan Singh Kulaste said in a written reply in the Lok Sabha.
He was asked whether the WHO has asked member countries, including India, to develop R&D blueprint to accelerate life-saving R&D during epidemics due to seasonal outbreaks like dengue, malaria and swine flu.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.